The FDA is calling on drug makers of some popular pain relievers to strengthen their warning labels after a review of new safety information. The warning labels on non-aspirin nonsteroidal anti-inflammatory drugs, known as NSAIDs, must be udpated to identify an increased risk of a heart attack or stroke. Via CNN. Posted July 10, 2015.
